Pulse Biosciences (PLSE) Capital Expenditures Growth (3y) (2018 - 2025)
Pulse Biosciences (PLSE) Capital Expenditures Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.02 Bn | 120.80 Bn | 1.96 Bn | -29.93% |
| 2 | Becton Dickinson | 44.98 Bn | 44.16 Bn | 2.15 Bn | -11.61% |
| 3 | Alcon | 33.05 Bn | 31.39 Bn | 1.53 Bn | -10.15% |
| 4 | Medline | 33.00 Bn | 30.76 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.50 Bn | 27.84 Bn | 890.98 Mn | 5.31% |
| 6 | West Pharmaceutical Services | 23.22 Bn | 22.79 Bn | 329.20 Mn | -16.94% |
| 7 | Solventum | 14.05 Bn | 13.48 Bn | 1.10 Bn | 8.92% |
| 8 | Cooper Companies | 13.91 Bn | 13.77 Bn | 735.40 Mn | 5.49% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | -21.70% |
| 10 | Pulse Biosciences | 2.16 Bn | 2.08 Bn | - | 36.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.82% |
| Sep 30, 2025 | 44.22% |
| Jun 30, 2025 | -26.15% |
| Mar 31, 2025 | -1.25% |
| Dec 31, 2024 | 28.31% |
| Sep 30, 2024 | -28.10% |
| Jun 30, 2024 | -44.78% |
| Dec 31, 2023 | 29.02% |
| Sep 30, 2023 | -28.15% |
| Jun 30, 2023 | 30.56% |
| Mar 31, 2023 | -38.90% |
| Dec 31, 2022 | 45.94% |
| Sep 30, 2022 | -51.18% |
| Jun 30, 2022 | 59.33% |
| Mar 31, 2022 | -15.66% |
| Dec 31, 2021 | -118.02% |
| Sep 30, 2021 | 29.67% |
| Jun 30, 2021 | -11.49% |
| Mar 31, 2021 | 14.47% |
| Dec 31, 2020 | -59.02% |